U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
436
Name Type Language
LANADELUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Lanadelumab [WHO-DD]
Common Name English
lanadelumab [INN]
Common Name English
LANADELUMAB [USAN]
Common Name English
LANADELUMAB [PURPLE BOOK CDER]
Common Name English
LANADELUMAB-FLYO
Official Name English
TAK-743
Common Name English
DX-2930
Code English
LANADELUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PLASMA KALLIKREIN) (HUMAN MONOCLONAL DX-2930 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL DX-2930 LIGHT CHAIN, DIMER
Common Name English
LANADELUMAB (SHP643)
Common Name English
Lanadelumab flyo [WHO-DD]
Common Name English
SHP-643
Code English
TAKHZYRO
Brand Name English
LANADELUMAB [JAN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/15/1551
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
WHO-ATC B06AC05
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
FDA ORPHAN DRUG 397213
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
Code System Code Type Description
SMS_ID
100000174876
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
RXCUI
2055641
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
DRUG BANK
DB14597
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
CLINICAL_TRIALS.GOV
NCT04070326
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
LACTMED
Lanadelumab
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
NCI_THESAURUS
C166535
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
ChEMBL
CHEMBL3545189
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
MERCK INDEX
m12083
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
DRUG CENTRAL
5309
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
FDA UNII
2372V1TKXK
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
DAILYMED
2372V1TKXK
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
USAN
CD-54
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
RXCUI
2055640
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
ALTERNATIVE
CAS
1426055-14-2
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
WIKIPEDIA
Lanadelumab
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
INN
10265
Created by admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
PRIMARY
ACTIVE MOIETY
LANADELUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966